16p13.11 microduplication in 14 fetuses: prenatal diagnosis and postnatal follow-up

Yuchun Pan1, Yu Hu1, Chonglan Gao1

  • 1Department of Prenatal Diagnosis, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic and Science and Technology of China, Chengdu, 611731, Sichuan, China.

Molecular Cytogenetics
|November 1, 2025
PubMed
Abstract

Insights

Prenatal diagnosis of 16p13.11 microduplication revealed nonspecific fetal phenotypes but frequent ultrasound abnormalities. Most infants with this genetic condition showed normal postnatal development, highlighting the importance of genetic counseling and follow-up.

Area of Science:

  • Genetics
  • Prenatal Diagnosis
  • Pediatrics

Background:

  • 16p13.11 microduplication is a rare genetic disorder with limited data on fetal cases.
  • Understanding prenatal diagnosis and postnatal outcomes is crucial for affected pregnancies.

Purpose of the Study:

  • To analyze prenatal diagnosis indications for fetuses with 16p13.11 microduplication.
  • To assess postnatal follow-up and explore genotype-phenotype correlations.

Main Methods:

  • Retrospective analysis of 4552 pregnant women undergoing amniocentesis for SNP-array.
  • Identification and characterization of 14 fetuses with 16p13.11 microduplication.

Main Results:

  • Microduplications ranged from 0.8 to 1.65 Mb.
  • Indications included high-risk screening, advanced maternal age, abnormal history, known carrier status, and ultrasound abnormalities.
  • Most affected infants had normal postnatal follow-up, with a few exhibiting sensorineural hearing loss, developmental delay, or VSD.

Conclusions:

  • Fetuses with 16p13.11 microduplication often present with nonspecific prenatal phenotypes but may show ultrasound abnormalities.
  • Postnatal outcomes are generally favorable, emphasizing the value of systematic review for genetic counseling and patient management.